Back
Viking Therapeutics 10K Form
Sell
45
VKTX
Viking Therapeutics
Last Price:
63.15
Seasonality Move:
38.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VKTX News And Ratings
See the #1 stock for the next 7 days that we like better than VKTX
VKTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-21.96M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.18 |
| Price / Book: | 7.72 |
Profitability
| EPS (TTM): | -0.93000 |
|---|---|
| Net Income (TTM): | $-99.15M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Viking Therapeutics Earnings Forecast
Key Viking Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Viking Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VKTX |
| CUSIP: | 92686J |
| Website: | vikingtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VKTX Technical Analysis vs Fundamental Analysis
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Sell
The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.